Does BEVACIZUMAB-MALY Cause Decreased appetite? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Decreased appetite have been filed in association with BEVACIZUMAB-MALY (ALYMSYS). This represents 6.6% of all adverse event reports for BEVACIZUMAB-MALY.
8
Reports of Decreased appetite with BEVACIZUMAB-MALY
6.6%
of all BEVACIZUMAB-MALY reports
0
Deaths
1
Hospitalizations
How Dangerous Is Decreased appetite From BEVACIZUMAB-MALY?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB-MALY.
What Other Side Effects Does BEVACIZUMAB-MALY Cause?
Asthenia (13)
Neutropenia (11)
Nausea (9)
Death (8)
Mucosal inflammation (7)
Aspartate aminotransferase increased (6)
Blood alkaline phosphatase increased (6)
Gamma-glutamyltransferase increased (6)
Thrombocytopenia (6)
Glaucoma (5)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which BEVACIZUMAB-MALY Alternatives Have Lower Decreased appetite Risk?
BEVACIZUMAB-MALY vs BEXAROTENE
BEVACIZUMAB-MALY vs BEZAFIBRATE
BEVACIZUMAB-MALY vs BEZLOTOXUMAB
BEVACIZUMAB-MALY vs BGB-11417
BEVACIZUMAB-MALY vs BICALUTAMIDE